ClinicalTrials.Veeva

Menu

Sprayshield as Adhesion Barrier System for Obese Patients

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Severe Obesity

Treatments

Procedure: ablation of gastric

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The application of SprayShield during a laparoscopic band removal (first surgical step) will be evaluated to see if the postoperative adhesions between the stomach, the left liver and the diaphragm are not severe, facilitating the surgical surgical step of a gastric bypass or a sleeve gastrectomy.

Full description

Monocenter and observational study on 20 obese patients, requiring removal of the gastric band for poor results (weight regain or insufficient weight-loss) or mechanical complications of the band ( slippage, esophageal dilation) and schedule for a second step surgery of gastric bypass or sleeve gastrectomy 2 months later.

Enrollment

20 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obese male or female who would benefit from a gastric band removal and for whom a second surgical step with conversion to sleeve gastrectomy or bypass is scheduled

Exclusion criteria

  • The patients having an ablation of ring motivated for an infectious complication

Trial design

20 participants in 1 patient group

Sprayshield
Description:
Applied to the operating zone during an ablation of gastric died ring at obese patients programmed for the second bariatric surgery to type of bypass gastric or of gastrectomie
Treatment:
Procedure: ablation of gastric

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems